首页> 美国卫生研究院文献>Bone Research >MicroRNA-26a inhibits osteosarcoma cell proliferation by targeting IGF-1
【2h】

MicroRNA-26a inhibits osteosarcoma cell proliferation by targeting IGF-1

机译:MicroRNA-26a通过靶向IGF-1抑制骨肉瘤细胞增殖

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

There are still controversies about the roles of microRNA-26a (miR-26a) in human malignancies, as it is a tumor suppressor in breast cancer, gastric cancer, and hepatocellular carcinoma, but is an oncogene in glioma and cholangiocarcinoma. Until now, the function of miR-26a in osteosarcoma remains largely elusive. Here, we found that miR-26a was downregualted in osteosarcoma tissues. Using in vitro and in vivo assays, we confirmed that miR-26a could inhibit the abilities of in vitro proliferation and suppress in vivo tumor growth in mouse model. Furthermore, we identified insulin-like growth factor 1 (IGF-1) as a novel and direct target of miR-26a and revealed that miR-26a exerted its tumor-suppressor function, at least in part, by inhibiting IGF-1 expression. These findings contribute to our understanding of the functions of miR-26a in osteosarcoma.
机译:关于microRNA-26a(miR-26a)在人类恶性肿瘤中的作用仍存在争议,因为它是乳腺癌,胃癌和肝细胞癌的抑癌基因,但在神经胶质瘤和胆管癌中是癌基因。到目前为止,miR-26a在骨肉瘤中的功能仍然很难捉摸。在这里,我们发现miR-26a在骨肉瘤组织中表达下调。使用体外和体内试验,我们证实miR-26a可以抑制小鼠模型中体外增殖的能力并抑制体内肿瘤的生长。此外,我们确定胰岛素样生长因子1(IGF-1)作为miR-26a的新型直接靶标,并揭示了miR-26a至少部分通过抑制IGF-1的表达发挥其肿瘤抑制功能。这些发现有助于我们了解miR-26a在骨肉瘤中的功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号